The Series D round of funding $100m was raised by Viz.ai, a platform that uses AI to detect and coordinate diseases and other care. It is based in San Francisco, CA and Tel Aviv (Israel).
Insight Partners, Tiger Global, and Threshold led the round. Other early backers included Kleiner Perkins and Threshold as well.
The company plans to use these funds to expand its platform to diagnose and triage other diseases and increase its customer base worldwide.
Chris Mansi is the CEO and co-founder of Viz.ai. Viz.ai utilizes AI algorithms to improve diagnosis and care in a range of acute and emerging diseases. Intelligent care coordination combines synchronized care collaboration, high-fidelity mobile image viewing, automated workflows, and better visibility at decision making moments. Viz.ai’s comprehensive neurovascular and vascular AI platform is clinically proven to save time and improve patient outcomes and access to care and is used in more than 1,000 hospitals in the US and EMEA. Mount Sinai Health System is a customer, as well as Thomas Jefferson University, Banner Health and CommonSpirit Health. HCA Healthcare is an investor.
The company’s offices are located in San Francisco and Tel Aviv.